Clinical Trial Update: A 10-Week Study for Efficacy and Safety Study of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the efficacy and safety of Gabitril (tiagabine) in adults with generalized anxiety disorder has completed. The 10-week study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Anxiety Disorder

Drugs mentioned

• Gabitril (tiagabine)

Snippet

Sponsor: Cephalon | Conditions: Generalized Anxiety Disorder | Phase 3 | Status: COMPLETED